NCT02445703
Comparison of Immunization Schedules of Inactivated Hepatitis A Vaccine and Combined Hepatitis A and Hepatitis B Vaccine prevention 4 completed NCT02112890
Study to Assess Seroprevalence of Hepatitis A, Hepatitis B and Bordetella Pertussis in Mexico No drug interventions Not Available Not Available completed NCT00621764
Immunogenicity and Safety of ChimeriVax™ Japanese Encephalitis Vaccine in Thai Toddlers and Children prevention 2 completed NCT00197184
Long Term Follow-up Study at Years 2, 3, 4 and 5 Where 2 Dosing Schedules of the Combined Hepatitis A and B Vaccine Were Compared prevention 3 completed NCT00338351
Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine. No drug interventions prevention 2 completed NCT06460545
Phase IV Study of Concomitant Administration of the sIPV and HepA No drug interventions prevention 4 not_yet_recruiting NCT00326183
Hepatitis A Vaccine, Inactivated and Measles, Mumps, Rubella and Varicella Virus Vaccine Live Safety Study (V251-066)(COMPLETED) prevention 4 completed NCT00197171
Long Term F/U Studies at Y5&6 to Demonstrate the Equivalence of 2 Vaccination Schedules of Combined Hepatitis A & B Vaccine No drug interventions prevention 3 completed NCT00684671
Evaluation of Immune Memory to Twinrix or Comparator by Challenge Dose Administration 4 Years After Primary Vaccination prevention 4 completed NCT00875485
Evaluation of Antibody Persistence & Immune Memory in Subjects Vaccinated During Adolescence With Twinrix™ No drug interventions prevention 4 completed NCT02124785
Evaluation of the Long-term Persistence of Hepatitis A Antibodies in Healthy Adults Who Were Vaccinated 21-25 Years Earlier With GlaxoSmithKline (GSK) Biologicals' Hepatitis A Vaccine, Havrix® No drug interventions prevention 4 withdrawn NCT00197015
Immunogenicity & Safety of Hepatitis A Vaccine Co-admin With a Measles/Mumps/Rubella & a Varicella Vaccine in Children prevention 3 completed NCT00603252
Study to Show That the Combined Hepatitis A and B Vaccine is Non-inferior to Monovalent Vaccines in Adults prevention 4 completed NCT00483470
Immunogenicity and Safety of Sanofi Pasteur's AVAXIM 80U Pediatric Vaccine Followed by Booster Dose prevention 3 completed NCT03312699
Effects of Aging on Primary and Secondary Vaccine Responses in a 15-Year Longitudinal Cohort basic_science 1 completed NCT00197249
Comparative Study in Healthy Adults Aged 18-50 Yrs Administered With Hepatyrix or Havrix+Typherix or Tiphim Vi, to Compare Reactogenicity & Immunogenicity prevention 3 completed NCT00197236
Immunogenicity and Safety of Havrix™ Co-Administered With a Diphtheria, Tetanus and Pertussis and a Haemophilus b Vaccine in Children Aged 15 Months prevention 3 completed NCT00926419
Serological Evaluation of Varicella and Hepatitis A Vaccines Using Injector Delivery prevention 2 / 3 unknown_status NCT00197119
Long-Term Follow-Up Studies at Year 6, 7, 8, 9, 10: 2 Formulations of Combined Hepatitis A/B Vaccine Compared in Subjects Aged 12-15 Years prevention 3 completed NCT06576024
Immunogenicity and Safety of Inactivated Hepatitis A Vaccine in HIV-infected People No drug interventions prevention 4 recruiting NCT03445416
Increasing Healthcare Engagement Via Routine Vaccination Among Young Black Men Who Have Sex With Men No drug interventions health_services_research Not Available withdrawn NCT00139139
A Study to Compare the Efficacy of Hepatitis A Vaccine and Immune Globulin When Given After Exposure to Hepatitis A prevention Not Available completed NCT06184230
Persistence of Hepatitis A Antibody in Healthy Adults ~32 Years Post Vaccination. basic_science 4 not_yet_recruiting NCT01453348
Study to Evaluate the Safety and Immunogenicity of Combined Hepatitis A/B Vaccine With MenACWY-CRM Conjugate Vaccine prevention 3 completed NCT01949857
The Immunogenicity and Safety of Inactivated and Live Attenuated Hepatitis A Vaccines prevention 4 completed NCT00289757
Long-Term Immune Persistence of GlaxoSmithKline Biologicals' Inactivated Hepatitis A Vaccine, Injected According to 0, 6-month Schedule prevention 4 completed NCT02135666
Evaluation of the Long-term Hepatitis A and B Antibody Persistence in Healthy Adult Subjects, Primed 16 to 20 Years Earlier With GSK Biologicals' Combined Hepatitis A and B Vaccine, Twinrix® (SB208127) in Study HAB-084 (208127/084) No drug interventions prevention 4 withdrawn NCT02002065
The Fifth-year Follow-up Study for the Phase IV Clinical Trial of Hepatitis A Vaccine in Healthy Children No drug interventions Not Available Not Available completed NCT00244374
A Randomized Trial of Vaccine Adherence in Young Injection Drug Users prevention Not Available completed NCT00289731
Effect of Risk Factors Likely to Influence Immuno of Combined Hepatitis A & B Vacc vs Monovalent Hepatitis A & B Vacc prevention 4 completed NCT05613127
To Evaluate the Immunogenicity and Safety of Inactivated Hepatitis A Vaccine in Healthy Children Aged From 24mons-15yrs prevention 3 not_yet_recruiting NCT01349829
A Study to Evaluate the Safety and Immunogenicity of the Hepatitis A Virus Vaccine HAVpur in Healthy Young Children prevention 4 completed NCT01353989
Hepatitis A Vaccination in the Elderly No drug interventions Not Available Not Available completed NCT02300792
The Effects of Honey, as a Dietary Supplement in Children With Hepatitis A No drug interventions treatment 2 completed NCT00289744
Long-Term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,6 Month Schedule prevention 3 completed NCT02601040
Immunogenicity and Safety of Inactivated and Live Attenuated Hepatitis A Vaccines prevention 4 completed NCT01160081
Seroprevalence Study of Hepatitis A, Varicella-Zoster, Cytomegalovirus, Herpes Simplex and Bordetella Pertussis No drug interventions Not Available Not Available completed NCT00313950
Immunogenicity and Safety of Hepatitis A Vaccine Given at the Same Time of Measles, Mumps, Rubella Combined Vaccine prevention 4 completed NCT06298708
Immunogenicity and Safety of Inactivated and Live-attenuated HAV Vaccine Among Thai Healthy Children and Adolescents prevention 3 active_not_recruiting NCT00197002
Immune Response & Safety of a Hepatitis A Vaccine Given Together With a Pneumococcal Vaccine in Healthy Children 15 m of Age prevention 3 completed NCT00451984
Hepatitis Vaccination in HIV Infection: Role of Adjuvant Interleukin-2 prevention 3 unknown_status NCT01405677
Safety and Immunogenicity of a Paediatric Dose of Virosomal Hepatitis A Vaccine prevention 2 completed NCT03231605
Comparative Immunogenicity Study of Two Hepatitis A Vaccines prevention 4 unknown_status NCT03330171
Safety and Immunogenicity of Measles Vaccine, Varicella Vaccine and Hepatitis-A Vaccine prevention 4 unknown_status NCT00534885
Safety, Immunogenicity, and Immune Persistence Study of an Inactivated Hepatitis A Vaccine prevention 4 completed NCT00289770
Long-term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,1,6 Mth Schedule in Healthy Adults prevention 3 completed NCT01838070
Regulatory Post-Marketing Surveillance Study for Hepatitis A Vaccine (AVAXIM 160U) No drug interventions Not Available Not Available completed NCT01307436
Long Term Follow-up of a Study to Assess the Safety and Immunogenicity of a Hepatitis A Vaccine Administered With and in the Absence of DTPaHibIPV, OPV and MMR Vaccines prevention 3 completed NCT00139113
Immunogenicity Study of an Inactivated Hepatitis A Vaccine in Infants and Young Children prevention 4 completed NCT00289718
Long-Term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,1,6 Month Schedule prevention 3 completed NCT01000324
Antibody Persistence & Immune Memory in Healthy Adults Previously Vaccinated With Twinrix Adult prevention 4 completed NCT06058416
Immunogenicity and Safety of Hepatitis A Among People Aged 18-50 Years Old prevention 4 active_not_recruiting NCT04638335
What is the Anti-HAV Seroprevalence of Travelers >60 Years or Having Lived in a Tropical Country for >5 Years No drug interventions Not Available Not Available completed NCT02011763
Safety of Two Doses of Avaxim® 80U Pediatric (Inactivated Hepatitis A Vaccine) in Toddlers, Children and Adolescents prevention 4 completed NCT03855176
Effectiveness of Booster With 1 or 2 Doses of HAV Vaccine Among HIV-infected Patients prevention 4 completed NCT00291876
Long-Term Immune Persistence of GlaxoSmithKline Biologicals' Inactivated Hepatitis A Vaccine Injected According to a 0, 12-month Schedule prevention 4 completed NCT00237991
Safety of GlaxoSmithKline (GSK) Biologicals Hepatitis A Vaccine in Korean Population No drug interventions Not Available Not Available completed NCT01252680
Immunogenicity and Interchangeability of Two Inactivated Hepatitis A Vaccines prevention 4 completed NCT03183492
Immunogenicity and Persistence of GlaxoSmithKline (GSK) Biologicals' Havrix® in Healthy Adult Subjects Vaccinated at Infancy Under the Hepatitis A Universal Mass Vaccination (UMV) Program in Israel prevention 4 withdrawn NCT00735644
Study of ChimeriVax™-Japanese Encephalitis Vaccine in Toddlers in Thailand and the Philippines prevention 3 completed NCT01865968
Comparison of Immunogenicity and Safety of Inactivated and Live Attenuated Hepatitis A Vaccines in Young Adults No drug interventions prevention 4 completed NCT01037114
Long-term Persistence Study in Healthy Adults Previously Vaccinated With Twinrix Adult prevention 4 completed NCT01341808
Immunogenicity of Hepatitis A Vaccine in Inflammatory Bowel Disease (IBD) Patients prevention 4 completed NCT02605538
Hepatitis B in Cystic Fibrosis and Latent Tuberculosis Respectively prevention Not Available withdrawn NCT00119743
A Efficacy Against Otitis Media in Children With 11 Valent Pneumococcal Vaccine No drug interventions prevention 3 terminated